GSK | tickerfilter.com

Fundamental analysis

47%

Profitability 44%

Dept financing 24%

Liquidity 38%

Performance 58%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.08%

1 Month

-3.38%

3 Months

6.64%

6 Months

-1.19%

1 Year

-10.05%

2 Year

3.89%

Key data

Stock price

$37.43

P/E Ratio

14.50

DAY RANGE

$37.04 - $37.55

EPS

$3.00

52 WEEK RANGE

$31.72 - $45.92

52 WEEK CHANGE

-$10.05

MARKET CAP

91.005 B

YIELD

3.44%

SHARES OUTSTANDING

2.073 B

DIVIDEND

$0.4007

EX-DIVIDEND DATE

02-21-2025

NEXT EARNINGS DATE

04-30-2025

BETA

0.37

PUBLIC FLOAT

AVERAGE 10 VOLUME

$5,304,455

AVERAGE 30 VOLUME

$6,405,645

Company detail

CEO: Emma N. Walmsley
Region: US
Website: gsk.com
Employees: 90,100
IPO year: 1986

Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.

GSK - GSK plc